Search results
Found 1080 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine
Clinical Trials Coronavirus COVID-19 General Research
4 June 2020
On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country.
First patient recruited in key COVID-19 drug treatment trial
Clinical Trials Coronavirus COVID-19 General Research
4 June 2020
A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient.
New research finds half of UK parents uncomfortable with children returning to school
Coronavirus COVID-19 General Research
3 June 2020
Half of UK parents do not feel comfortable about their children attending school following lockdown, according to early results from a new study asking parents and carers about their children’s mental health through the COVID-19 crisis.
Nicotine therapy for coronavirus: the evidence is weak and contradictory
Coronavirus COVID-19 General Research
3 June 2020
First patient, a child, receives convalescent plasma through RECOVERY, the dedicated COVID-19 treatment trial
Clinical Trials Coronavirus COVID-19 General Research
3 June 2020
The first person to be randomly selected to receive convalescent plasma through RECOVERY has now received a transfusion.
Coronavirus and diabetes: the different risks for people with type 1 and type 2
Coronavirus COVID-19 General Research
2 June 2020
Coronavirus: is it safe for children to return to school?
Coronavirus COVID-19 General Research
2 June 2020
The Duke of Westminster donates £1m to Oxford University’s COVID-19 mental health research
Awards and Appointments Coronavirus COVID-19 General Research
29 May 2020
Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort.
COVID-19 drug trial could lead to enhanced respiratory care for patients
Clinical Trials Coronavirus COVID-19 General Research
29 May 2020
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
HCQ with antibiotics to treat COVID-19 could be dangerous for the heart
Coronavirus COVID-19 General Research
27 May 2020
Researchers from the Department of Physiology, Anatomy & Genetics (DPAG) have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
The UK prepares for national launch of COVID-19 digital contact tracing app with the help of Oxford Scientists
Coronavirus COVID-19 General Research
26 May 2020
The UK’s National Health Service (NHS) is finalising the release of a contact tracing app designed to slow the rate of infection for COVID-19. The tracing app, developed by the digital unit NHSx, is based on the evidence provided by a team of Oxford epidemiologists, mathematical modellers and ethicists in the Nuffield Department of Medicine, based at the Big Data Institute.
How has COVID-19 Impacted on People's Vulnerability to Mental Illness and Depression?
Coronavirus COVID-19 General Research
26 May 2020
The Oxford University COSIE study (COvid-19, Social Isolation and Emotion) is an online study which asked people about their experiences during the coronavirus lockdown in late April 2020, while also using objective tests of psychological function to measure vulnerability to mental illness such as depression.
Conspiracy beliefs reduces the following of government coronavirus guidance
Coronavirus COVID-19 General Research
22 May 2020
A new study from the University of Oxford shows that people who hold coronavirus conspiracy beliefs are less likely to comply with social distancing guidelines or take-up future vaccines.
Oxford COVID-19 vaccine to begin phase II/III human trials
Clinical Trials Coronavirus COVID-19 General Research
22 May 2020
University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers.
High COVID-19 mortality rates among those with liver disease, study finds
Coronavirus COVID-19 General Research
21 May 2020
A new international study has found high mortality rates from COVID-19 among people with chronic liver disease and cirrhosis.
Oxford leads on UK trial sites testing potential COVID-19 preventatives
Clinical Trials Coronavirus COVID-19 General Research
21 May 2020
The Diabetes Trial Unit (DTU) in the Radcliffe Department of Medicine is managing the UK sites for a global study testing if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers.
New Oxford Sparks podcast launched: How tricky is it to make a COVID-19 tracing app?
Coronavirus COVID-19 General Research
20 May 2020
In this episode of the Big Questions podcast, Dr Grant Blank (Oxford Internet Institute) gives his thoughts on how tricky it is to make a COVID-19 tracing app.
RECOVERY team reflect on International Clinical Trials Day 2020
Clinical Trials Coronavirus COVID-19 General Research
20 May 2020
How to set up a trial in nine days
Clinical Trials Coronavirus COVID-19 General Research
20 May 2020